Edition:
United States

ImmunoGen Inc (IMGN.OQ)

IMGN.OQ on NASDAQ Stock Exchange Global Select Market

2.85USD
22 Jul 2016
Change (% chg)

-- (+0.00%)
Prev Close
$2.85
Open
$2.85
Day's High
$2.89
Day's Low
$2.81
Volume
230,366
Avg. Vol
508,786
52-wk High
$19.09
52-wk Low
$2.69

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform -0.31 June 23 Jul 2016

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 3 4 4 4
(2) OUTPERFORM 0 0 0 1
(3) HOLD 5 5 5 4
(4) UNDERPERFORM 1 1 1 1
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 2.44 2.30 2.30 2.20

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Mar-16 9 23.17 29.64 19.60 --
Quarter Ending Jun-16 8 17.11 18.65 15.00 21.87
Year Ending Jun-16 9 69.21 70.40 67.00 87.39
Year Ending Jun-17 8 63.75 85.60 21.73 71.28
Earnings (per share)
Quarter Ending Mar-16 9 -0.31 -0.26 -0.37 --
Quarter Ending Jun-16 8 -0.39 -0.28 -0.42 -0.34
Year Ending Jun-16 9 -1.54 -1.42 -1.57 -1.31
Year Ending Jun-17 8 -1.66 -1.44 -1.82 -1.30

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Mar-16 23.17 19.71 3.46 14.92
Quarter Ending Dec-15 17.87 18.03 0.16 0.88
Quarter Ending Sep-15 15.84 14.85 0.99 6.26
Quarter Ending Jun-15 15.42 12.61 2.81 18.23
Quarter Ending Mar-15 20.95 11.43 9.52 45.45
Earnings (per share)
Quarter Ending Mar-16 -0.31 -0.37 0.06 -17.68
Quarter Ending Dec-15 -0.36 -0.38 0.02 -4.40
Quarter Ending Sep-15 -0.35 -0.39 0.04 -11.43
Quarter Ending Jun-15 -0.35 -0.35 0.00 -0.86
Quarter Ending Mar-15 -0.24 -0.25 0.01 -5.53

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Mar-16 23.17 -- -- -- --
Quarter Ending Jun-16 17.11 17.11 16.86 16.86 21.87
Year Ending Jun-16 69.21 69.21 69.22 69.22 87.39
Year Ending Jun-17 63.75 63.75 64.99 64.99 71.28
Earnings (per share)
Quarter Ending Mar-16 -0.31 -- -- -- --
Quarter Ending Jun-16 -0.39 -0.39 -0.39 -0.39 -0.34
Year Ending Jun-16 -1.54 -1.54 -1.54 -1.53 -1.31
Year Ending Jun-17 -1.66 -1.66 -1.66 -1.62 -1.30

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Mar-16 -- -- -- --
Quarter Ending Jun-16 0 0 0 0
Year Ending Jun-16 0 0 0 0
Year Ending Jun-17 0 0 0 0
Earnings
Quarter Ending Mar-16 -- -- -- --
Quarter Ending Jun-16 0 0 0 0
Year Ending Jun-16 0 0 0 0
Year Ending Jun-17 0 0 0 1

Analyst Research Reports

Report Title Price
Provider : Stock Traders Daily
$20.00
Provider : ValuEngine, Inc.
$25.00
Provider : S&P Capital IQ Quantitative Report
$104.00
Provider : Reuters Investment Profile
$20.00
Provider : Thomson Reuters Stock Report
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.